{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:45:17Z","timestamp":1792788317793,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Clinical Research Program of the Fourth Military Medical University","award":["2024LC2419"],"award-info":[{"award-number":["2024LC2419"]}],"id":[{"id":"https:\/\/ror.org\/00ms48f15","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The cerebellum plays a crucial role in cognitive processing and thus presents a promising therapeutic target for Alzheimer\u2019s disease (AD). This trial aims to evaluate the efficacy and safety\u00a0of long-term, neuronavigated cerebellar intermittent theta burst stimulation (iTBS) in patients with AD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The ACT-AD trial is a multicenter, randomized, double-blind, sham-controlled study involving 100 participants with mild-to-moderate AD across 4 centers in China. Participants will be randomized to receive either cerebellar iTBS or sham stimulation for 4\u00a0weeks (daily sessions), followed by 8\u00a0weeks of weekly maintenance sessions. The primary outcome is the change in the Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) score from baseline to week 12. Secondary outcomes include additional clinical scales. Exploratory outcomes include electroencephalogram (EEG),\u00a0blood biomarkers\u00a0and magnetic resonance imaging (MRI). Statistical analysis will follow intention-to-treat principles using mixed models for repeated measures (MMRM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The ACT-AD trial will assess the efficacy and safety of long-term, neuronavigated cerebellar iTBS in treating patients with mild-to-moderate AD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov, NCT06669182. Registered on 31 October 2024.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-026-10009-w","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:28:04Z","timestamp":1791516484000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advantage of cerebellar intermittent theta-burst stimulation in Alzheimer's disease (ACT-AD): study protocol for a multicenter, randomized, double-blind, sham-controlled trial"],"prefix":"10.1186","volume":"27","author":[{"given":"Xin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changgeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinuo","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gejuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0612-2917","authenticated-orcid":false,"given":"Wen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"issue":"10284","key":"10009_CR1","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, et al. Alzheimer\u2019s disease. Lancet. 2021;397(10284):1577\u201390.","journal-title":"Lancet"},{"issue":"7715","key":"10009_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/d41586-018-05717-6","volume":"559","author":"R Hodson","year":"2018","unstructured":"Hodson R. Alzheimer\u2019s disease. Nature. 2018;559(7715):S1.","journal-title":"Nature"},{"key":"10009_CR3","doi-asserted-by":"crossref","unstructured":"Passeri E, Elkhoury K, Morsink M, Broersen K, Linder M, Tamayol A, et al. Alzheimer\u2019s disease: treatment strategies and their limitations. Int J Mol Sci.\u00a02022;23(22):13954.\u00a0","DOI":"10.3390\/ijms232213954"},{"key":"10009_CR4","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jconrel.2024.09.012","volume":"375","author":"Y Jin","year":"2024","unstructured":"Jin Y, Du Q, Song M, Kang R, Zhou J, Zhang H, et al. Amyloid-\u03b2-targeting immunotherapies for Alzheimer\u2019s disease. J Control Release. 2024;375:346\u201365.","journal-title":"J Control Release"},{"issue":"12","key":"10009_CR5","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1093\/brain\/awae292","volume":"147","author":"G Koch","year":"2024","unstructured":"Koch G, Altomare D, Benussi A, Br\u00e9chet L, Casula EP, Dodich A, et al. The emerging field of non-invasive brain stimulation in Alzheimer\u2019s disease. Brain. 2024;147(12):4003\u201316.","journal-title":"Brain"},{"key":"10009_CR6","doi-asserted-by":"crossref","unstructured":"Menardi A, Rossi S, Koch G, Hampel H, Vergallo A, Nitsche MA, et al. Toward noninvasive brain stimulation 2.0 in Alzheimer's disease. Ageing Res Rev. 2022;75:101555.","DOI":"10.1016\/j.arr.2021.101555"},{"key":"10009_CR7","doi-asserted-by":"crossref","unstructured":"Yang C, Liu G, Chen X, Le W. Cerebellum in Alzheimer's disease and other neurodegenerative diseases: an emerging research frontier. MedComm (2020). 2024;5(7):e638.","DOI":"10.1002\/mco2.638"},{"issue":"3","key":"10009_CR8","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.neuron.2013.10.044","volume":"80","author":"RL Buckner","year":"2013","unstructured":"Buckner RL. The cerebellum and cognitive function: 25 years of insight from anatomy and neuroimaging. Neuron. 2013;80(3):807\u201315.","journal-title":"Neuron"},{"issue":"23","key":"10009_CR9","doi-asserted-by":"publisher","first-page":"8432","DOI":"10.1523\/JNEUROSCI.23-23-08432.2003","volume":"23","author":"RM Kelly","year":"2003","unstructured":"Kelly RM, Strick PL. Cerebellar loops with motor cortex and prefrontal cortex of a nonhuman primate. J Neurosci. 2003;23(23):8432\u201344.","journal-title":"J Neurosci"},{"issue":"26","key":"10009_CR10","doi-asserted-by":"publisher","first-page":"8586","DOI":"10.1523\/JNEUROSCI.1868-09.2009","volume":"29","author":"C Habas","year":"2009","unstructured":"Habas C, Kamdar N, Nguyen D, Prater K, Beckmann CF, Menon V, et al. Distinct cerebellar contributions to intrinsic connectivity networks. J Neurosci. 2009;29(26):8586\u201394.","journal-title":"J Neurosci"},{"issue":"4","key":"10009_CR11","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.brs.2022.06.004","volume":"15","author":"Q Yao","year":"2022","unstructured":"Yao Q, Tang F, Wang Y, Yan Y, Dong L, Wang T, et al. Effect of cerebellum stimulation on cognitive recovery in patients with Alzheimer disease: a randomized clinical trial. Brain Stimul. 2022;15(4):910\u201320.","journal-title":"Brain Stimul"},{"key":"10009_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2013.00002","volume":"5","author":"F Di Lorenzo","year":"2013","unstructured":"Di Lorenzo F, Martorana A, Ponzo V, Bonn\u00ec S, D\u2019Angelo E, Caltagirone C, et al. Cerebellar theta burst stimulation modulates short latency afferent inhibition in Alzheimer\u2019s disease patients. Front Aging Neurosci. 2013;5:2.","journal-title":"Front Aging Neurosci"},{"key":"10009_CR13","doi-asserted-by":"publisher","unstructured":"Zhang X, Sun Z, Wu D, Shi X, Song C, Guan X, et al. Effects of cerebellar intermittent theta-burst stimulation on patients with Alzheimer\u2019s disease: a randomized controlled trial. J Alzheimers Dis. 2025:13872877251366656. https:\/\/doi.org\/10.1177\/13872877251366656.","DOI":"10.1177\/13872877251366656"},{"issue":"4","key":"10009_CR14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr.","year":"2018","unstructured":"Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"10009_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/alzrt138","volume":"4","author":"J Cummings","year":"2012","unstructured":"Cummings J. Alzheimer\u2019s disease diagnostic criteria: practical applications. Alzheimers Res Ther. 2012;4(5):35.","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"10009_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/0269881107084002","volume":"22","author":"ZJ Daskalakis","year":"2008","unstructured":"Daskalakis ZJ, Christensen BK, Fitzgerald PB, Moller B, Fountain SI, Chen R. Increased cortical inhibition in persons with schizophrenia treated with clozapine. J Psychopharmacol. 2008;22(2):203\u20139.","journal-title":"J Psychopharmacol"},{"issue":"1","key":"10009_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.brs.2019.10.003","volume":"13","author":"N Olfati","year":"2020","unstructured":"Olfati N, Shoeibi A, Abdollahian E, Ahmadi H, Hoseini A, Akhlaghi S, et al. Cerebellar repetitive transcranial magnetic stimulation (rTMS) for essential tremor: a double-blind, sham-controlled, crossover, add-on clinical trial. Brain Stimul. 2020;13(1):190\u20136.","journal-title":"Brain Stimul"},{"issue":"12","key":"10009_CR18","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/j.clinph.2009.08.016","volume":"120","author":"S Rossi","year":"2009","unstructured":"Rossi S, Hallett M, Rossini PM, Pascual-Leone A. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009;120(12):2008\u201339.","journal-title":"Clin Neurophysiol"},{"issue":"8","key":"10009_CR19","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.exger.2013.05.001","volume":"48","author":"T Tan","year":"2013","unstructured":"Tan T, Xie J, Liu T, Chen X, Zheng X, Tong Z, et al. Low-frequency (1 Hz) repetitive transcranial magnetic stimulation (rTMS) reverses A\u03b2(1-42)-mediated memory deficits in rats. Exp Gerontol. 2013;48(8):786\u201394.","journal-title":"Exp Gerontol"},{"issue":"5","key":"10009_CR20","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00702-012-0902-z","volume":"120","author":"JM Rabey","year":"2013","unstructured":"Rabey JM, Dobronevsky E, Aichenbaum S, Gonen O, Marton RG, Khaigrekht M. Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer\u2019s disease: a randomized, double-blind study. J Neural Transm. 2013;120(5):813\u20139.","journal-title":"J Neural Transm"},{"key":"10009_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2013.00050","volume":"6","author":"F M\u00fcller-Dahlhaus","year":"2013","unstructured":"M\u00fcller-Dahlhaus F, Vlachos A. Unraveling the cellular and molecular mechanisms of repetitive magnetic stimulation. Front Mol Neurosci. 2013;6:50.","journal-title":"Front Mol Neurosci"},{"issue":"5544","key":"10009_CR22","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1126\/science.1067020","volume":"294","author":"ER Kandel","year":"2001","unstructured":"Kandel ER. The molecular biology of memory storage: a dialogue between genes and synapses. Science. 2001;294(5544):1030\u20138.","journal-title":"Science"},{"issue":"2","key":"10009_CR23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1113\/jphysiol.1973.sp010273","volume":"232","author":"TV Bliss","year":"1973","unstructured":"Bliss TV, Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol. 1973;232(2):331\u201356.","journal-title":"J Physiol"},{"issue":"11","key":"10009_CR24","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.clinph.2014.05.021","volume":"125","author":"JP Lefaucheur","year":"2014","unstructured":"Lefaucheur JP, Andr\u00e9-Obadia N, Antal A, Ayache SS, Baeken C, Benninger DH, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. 2014;125(11):2150\u2013206.","journal-title":"Clin Neurophysiol"},{"issue":"1","key":"10009_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-025-01709-7","volume":"17","author":"G Koch","year":"2025","unstructured":"Koch G, Casula EP, Bonn\u00ec S, Borghi I, Assogna M, Di Lorenzo F, et al. Effects of 52\u00a0weeks of precuneus rTMS in Alzheimer\u2019s disease patients: a randomized trial. Alzheimers Res Ther. 2025;17(1):69.","journal-title":"Alzheimers Res Ther"},{"issue":"11","key":"10009_CR26","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1093\/brain\/awac285","volume":"145","author":"G Koch","year":"2022","unstructured":"Koch G, Casula EP, Bonn\u00ec S, Borghi I, Assogna M, Minei M, et al. Precuneus magnetic stimulation for Alzheimer\u2019s disease: a randomized, sham-controlled trial. Brain. 2022;145(11):3776\u201386.","journal-title":"Brain"},{"issue":"32","key":"10009_CR27","doi-asserted-by":"publisher","first-page":"19538","DOI":"10.1073\/pnas.2002896117","volume":"117","author":"MI Sereno","year":"2020","unstructured":"Sereno MI, Diedrichsen J, Tachrount M, Testa-Silva G, d\u2019Arceuil H, De Zeeuw C. The human cerebellum has almost 80% of the surface area of the neocortex. Proc Natl Acad Sci U S A. 2020;117(32):19538\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10009_CR28","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.bandl.2012.11.001","volume":"127","author":"HJ De Smet","year":"2013","unstructured":"De Smet HJ, Paquier P, Verhoeven J, Mari\u00ebn P. The cerebellum: its role in language and related cognitive and affective functions. Brain Lang. 2013;127(3):334\u201342.","journal-title":"Brain Lang"},{"issue":"3","key":"10009_CR29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11065-010-9137-7","volume":"20","author":"CL Marvel","year":"2010","unstructured":"Marvel CL, Desmond JE. Functional topography of the cerebellum in verbal working memory. Neuropsychol Rev. 2010;20(3):271\u20139.","journal-title":"Neuropsychol Rev"},{"issue":"2","key":"10009_CR30","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s12311-011-0321-y","volume":"11","author":"LF Koziol","year":"2012","unstructured":"Koziol LF, Budding DE, Chidekel D. From movement to thought: executive function, embodied cognition, and the cerebellum. Cerebellum. 2012;11(2):505\u201325.","journal-title":"Cerebellum"},{"key":"10009_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.645171","volume":"12","author":"F Tang","year":"2021","unstructured":"Tang F, Zhu D, Ma W, Yao Q, Li Q, Shi J. Differences changes in cerebellar functional connectivity between mild cognitive impairment and Alzheimer\u2019s disease: a seed-based approach. Front Neurol. 2021;12:645171.","journal-title":"Front Neurol"},{"issue":"5","key":"10009_CR32","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10548-020-00781-6","volume":"33","author":"F Di Lorenzo","year":"2020","unstructured":"Di Lorenzo F, Bonn\u00ec S, Picazio S, Motta C, Caltagirone C, Martorana A, et al. Effects of cerebellar theta burst stimulation on contralateral motor cortex excitability in patients with Alzheimer\u2019s disease. Brain Topogr. 2020;33(5):613\u20137.","journal-title":"Brain Topogr"},{"issue":"12","key":"10009_CR33","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, R\u00fcb U, Orantes M, Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology. 2002;58(12):1791\u2013800.","journal-title":"Neurology"},{"key":"10009_CR34","doi-asserted-by":"publisher","first-page":"106981","DOI":"10.1016\/j.nlm.2019.01.004","volume":"170","author":"KJ Liang","year":"2020","unstructured":"Liang KJ, Carlson ES. Resistance, vulnerability and resilience: a review of the cognitive cerebellum in aging and neurodegenerative diseases. Neurobiol Learn Mem. 2020;170:106981.","journal-title":"Neurobiol Learn Mem"},{"key":"10009_CR35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neurobiolaging.2021.11.005","volume":"111","author":"L Pini","year":"2022","unstructured":"Pini L, Pizzini FB, Boscolo-Galazzo I, Ferrari C, Galluzzi S, Cotelli M, et al. Brain network modulation in Alzheimer\u2019s and frontotemporal dementia with transcranial electrical stimulation. Neurobiol Aging. 2022;111:24\u201334.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"10009_CR36","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1176\/appi.neuropsych.20110279","volume":"34","author":"KM Daigle","year":"2022","unstructured":"Daigle KM, Pietrzykowski MO, Waters AB, Swenson LP, Gansler DA. Central executive network and executive function in patients with Alzheimer\u2019s disease and healthy individuals: meta-analysis of structural and functional MRI. J Neuropsychiatry Clin Neurosci. 2022;34(3):204\u201313.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"47","key":"10009_CR37","doi-asserted-by":"publisher","first-page":"18760","DOI":"10.1073\/pnas.0708803104","volume":"104","author":"C Sorg","year":"2007","unstructured":"Sorg C, Riedl V, M\u00fchlau M, Calhoun VD, Eichele T, L\u00e4er L, et al. Selective changes of resting-state networks in individuals at risk for Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2007;104(47):18760\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10009_CR38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11065-014-9249-6","volume":"24","author":"EL Dennis","year":"2014","unstructured":"Dennis EL, Thompson PM. Functional brain connectivity using fMRI in aging and Alzheimer\u2019s disease. Neuropsychol Rev. 2014;24(1):49\u201362.","journal-title":"Neuropsychol Rev"},{"issue":"4","key":"10009_CR39","doi-asserted-by":"publisher","first-page":"828.e19","DOI":"10.1016\/j.neurobiolaging.2011.06.024","volume":"33","author":"JS Damoiseaux","year":"2012","unstructured":"Damoiseaux JS, Prater KE, Miller BL, Greicius MD. Functional connectivity tracks clinical deterioration in Alzheimer\u2019s disease. Neurobiol Aging. 2012;33(4):828.e19-30.","journal-title":"Neurobiol Aging"},{"issue":"40","key":"10009_CR40","doi-asserted-by":"publisher","first-page":"12686","DOI":"10.1523\/JNEUROSCI.3189-09.2009","volume":"29","author":"T Hedden","year":"2009","unstructured":"Hedden T, Van Dijk KR, Becker JA, Mehta A, Sperling RA, Johnson KA, et al. Disruption of functional connectivity in clinically normal older adults harboring amyloid burden. J Neurosci. 2009;29(40):12686\u201394.","journal-title":"J Neurosci"},{"issue":"10","key":"10009_CR41","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1093\/cercor\/bhr025","volume":"21","author":"EC Mormino","year":"2011","unstructured":"Mormino EC, Smiljic A, Hayenga AO, Onami SH, Greicius MD, Rabinovici GD, et al. Relationships between \u03b2-amyloid and functional connectivity in different components of the default mode network in aging. Cereb Cortex. 2011;21(10):2399\u2013407.","journal-title":"Cereb Cortex"},{"issue":"1","key":"10009_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-023-01181-1","volume":"15","author":"B Jiao","year":"2023","unstructured":"Jiao B, Li R, Zhou H, Qing K, Liu H, Pan H, et al. Neural biomarker diagnosis and prediction to mild cognitive impairment and Alzheimer\u2019s disease using EEG technology. Alzheimers Res Ther. 2023;15(1):32.","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"10009_CR43","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3233\/JAD-220508","volume":"91","author":"MHF Fischer","year":"2023","unstructured":"Fischer MHF, Zibrandtsen IC, H\u00f8gh P, Musaeus CS. Systematic review of EEG coherence in Alzheimer\u2019s disease. J Alzheimers Dis. 2023;91(4):1261\u201372.","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"10009_CR44","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.neuron.2024.02.017","volume":"112","author":"D Zhang","year":"2024","unstructured":"Zhang D, Zhang W, Ming C, Gao X, Yuan H, Lin X, et al. P-tau217 correlates with neurodegeneration in Alzheimer\u2019s disease, and targeting p-tau217 with immunotherapy ameliorates murine tauopathy. Neuron. 2024;112(10):1676-93.e12.","journal-title":"Neuron"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-10009-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-10009-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-10009-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:02:31Z","timestamp":1791579751000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-10009-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10009"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-10009-w","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"8 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The trial protocol was approved by the Ethics office of Xijing Hospital (approval number, KY20242285). All participants or their representatives provided written informed consent before participation in the trial.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. No identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent form are available from the corresponding author on request.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"601"}}